Synthesis, Characterization and Glyoxalase Inhibitory Activity of 4,6-Diheteroarylpyrimidine-2-amine Derivatives: In Vitro and In Silico Studies | ||||
| Egyptian Journal of Chemistry | ||||
| Volume 68, Issue 2, February 2025, Page 183-192 PDF (569.6 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejchem.2024.289371.9720 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Mohammad Murwih Alidmat1, 2; Maram B. Alhawarri2; Mahmoud Al-Refai3; Iman A. Mansi3; Qosay Al-Balas4; Mohammad M. Ibrahim   1
| ||||
| 1Department of Chemistry, Faculty of Science, Al al-Bayt University, P.O.BOX 130040, Al-Mafraq 25113, Jordan | ||||
| 2Department of Pharmacy, Faculty of Pharmacy, Jadara University, P.O.Box 733, Irbid 21110, Jordan. | ||||
| 3Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical sciences, The Hashemite University, Zarqa, Jordan. | ||||
| 4Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan. | ||||
| Abstract | ||||
| New series of 4,6-diheteroarylpyrimidine-2ـamines (4a-e) and (5a-c) were prepared by cyclization of particular chalcones (2) or (3) with guanidine nitrate in the presence of potassium hydroxide. Chalcones (2) and (3) were prepared by base-catalyzed Claisen-Schmidt condensation of heteroaryl aldehydes (1) with 2-acetyl-5-chlorothiophene and 3-acetyl-2,5-dichlorothiophene, respectively. All the newly synthesized compounds were characterized by spectroscopic and spectrometric techniques such as IR, 1H NMR, 13C NMR and mass spectrometry. This study evaluated in vitro glyoxalase I (GLO-I) inhibitory activity, coupled with molecular docking analysis. Spectroscopic methods confirmed the structures, and structure-activity relationship was established, revealing the importance of chloro substitutions and a furan ring for enhanced inhibition. In vitro glyoxalase inhibitory activity showed that 5b has excellent inhibitory activity against the glyoxalase I enzyme, with an IC50 of 15 µM. Molecular docking using AutoDock 4.2 highlighted key interactions within the active site of the human glyoxalase I enzyme, underscoring the absence of direct Zn interactions in the synthesized compounds compared to the cocrystallized ligand and revealing the need for structural optimization to introduce metal-binding functionalities. This research paves the way for the rational design of more potent glyoxalase I inhibitors, contributing significantly to the field of enzyme inhibition and therapeutic agent development. | ||||
| Keywords | ||||
| Pyrimidines; Glyoxalase-I; Molecular Docking | ||||
|
Statistics Article View: 678 PDF Download: 182 |
||||
